NAPIGEN, Inc. Receives Patent for Revolutionary CRISPR Technology in Organelle Genome Editing
Key Takeaways: Innovative Patent Awarded: NAPIGEN, Inc. secures a U.S. patent for CRISPR technologies targeting organellar genomes, a pioneering advancement in genetic engineering. Agricultural and Healthcare Impact: The technology promises […]